For both PDCs, we observed a significant decrease of several genes already found to be involved in GBM aggressiveness such as ROCK1 [18, 31], LIMS1 [18], SKP2 [32], NFE2L2 [33], RAB21 [34]. Here, NFE2L2 is linked to glioblastoma.